Treatment with soluble TNF receptor exacerbates murine psoriasis-like disease and symptoms are related to increased expression of the Th17 associated cytokines such as IL-1β, IL-6, IL-17, IL-21, IL-22, and reduction of Treg cells (Ma et al. 2010). This evidence concerns the gene IL17A and psoriasis.